- Home
- AKRO vs ENVA Comparison
AKRO vs ENVA Comparison
Compare AKRO & ENVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AKRO
- ENVA
- Stock Information
- Founded
- AKRO 2017
- ENVA 2011
- Country
- AKRO United States
- ENVA United States
- Employees
- AKRO N/A
- ENVA N/A
- Industry
- AKRO Biotechnology: Pharmaceutical Preparations
- ENVA Finance: Consumer Services
- Sector
- AKRO Health Care
- ENVA Finance
- Exchange
- AKRO Nasdaq
- ENVA Nasdaq
- Market Cap
- AKRO 2.8B
- ENVA 2.3B
- IPO Year
- AKRO 2019
- ENVA N/A
- Fundamental
- Price
- AKRO $39.85
- ENVA $94.64
- Analyst Decision
- AKRO Strong Buy
- ENVA Buy
- Analyst Count
- AKRO 9
- ENVA 6
- Target Price
- AKRO $76.29
- ENVA $126.80
- AVG Volume (30 Days)
- AKRO 1.1M
- ENVA 282.9K
- Earning Date
- AKRO 05-16-2025
- ENVA 04-29-2025
- Dividend Yield
- AKRO N/A
- ENVA N/A
- EPS Growth
- AKRO N/A
- ENVA 52.89
- EPS
- AKRO N/A
- ENVA 8.48
- Revenue
- AKRO N/A
- ENVA $1,304,376,000.00
- Revenue This Year
- AKRO N/A
- ENVA $155.12
- Revenue Next Year
- AKRO N/A
- ENVA $13.07
- P/E Ratio
- AKRO N/A
- ENVA $11.15
- Revenue Growth
- AKRO N/A
- ENVA 21.58
- 52 Week Low
- AKRO $17.86
- ENVA $57.46
- 52 Week High
- AKRO $58.40
- ENVA $117.56
- Technical
- Relative Strength Index (RSI)
- AKRO 44.56
- ENVA 50.60
- Support Level
- AKRO $41.60
- ENVA $90.92
- Resistance Level
- AKRO $46.47
- ENVA $96.03
- Average True Range (ATR)
- AKRO 2.26
- ENVA 3.21
- MACD
- AKRO 0.08
- ENVA 0.12
- Stochastic Oscillator
- AKRO 21.84
- ENVA 47.02
About AKRO Akero Therapeutics Inc.
Akero Therapeutics Inc is a clinical-stage biotechnology company focused on developing and commercializing transformative treatments for serious metabolic diseases with high unmet medical needs. Its focus is nonalcoholic steatohepatitis (MASH), or NASH, a disease without any approved therapies. The company's product candidate efruxifermin is an FGF21 analog with properties that have the potential to address the core processes underlying NASH pathogenesis.
About ENVA Enova International Inc.
Enova International Inc provides online financial services, including short-term consumer loans, line of credit accounts, and installment loans to customers mainly in the United States and and Brazil. Consumers apply for credit online, the company's technology platforms process the applications, and transactions are completed quickly and efficiently. Its customers are predominantly retail consumers and small businesses. Enova markets its financing products under the names CashNetUSA, NetCredit, OnDeck, Headway Capital, and Simplic. The company also operates a money transfer platform under the name Pangea. Geographically, the company generates a majority of its revenue from its business in the United States and the rest from other international countries.